Researchers at the Indian Institute of Science have collaborated with colleauges at Oslo University Hospital and the University of Agder to develop a new software tool called the AnamNet, which detects the severity of lung infections in Covid-19 patients. The tool analyses chest CT scans to identify abnormalities in the lungs using deep learning techniques.

WorldQuant Predictive, an artificial intelligence (AI) company, and CAS, a division of the American Chemical Society, have entered into a partnership to develop an AI-powered virtual screening tool that will help researchers to quickly prioritise the most promising drugs for treating Covid-19 and other critical illnesses. The project aims to cut critical time to find cures of diseases to one week rather than the typical six to eight weeks.

Universal PropTech has completed an investment in data analytics company ISBRG for a minority interest and secured defined agency rights to the company’s SpotLight-19 technology. SpotLight-19 is designed to detect SARS-CoV-2 infection in less than 60 seconds using a non-invasive scan of a person’s finger with a harmless beam of light. As per the agreement, PropTech will have the exclusive rights to sell the technology and other future platform offerings to education and government sectors in Canada.

Sense Biodetection, a molecular diagnostics company, has announced the appointment of senior executives to lead the commercialisation of its products to provide patient-focused decentralised healthcare. The company has established a new distribution centre in Boston, Massachusetts as it prepares to launch its Veros Covid-19 test in the US and globally.